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ABSTRACT 
 
Fibroblasts are important in wound healing as they can create tension, migrate 
into a wound, and differentiate into myofibroblasts that produce a contractile force to 
close the wound. Replicative senescence, or the limit of the number of times a cell 
divides, may influence the ability of the fibroblast to heal the wound. This study was 
designed to investigate the formation of myofibroblasts, contraction ability and migration 
rate of three populations of cells derived from the same cell line:  1) those with early 
population doublings, 2) those with late population doublings and 3) cells that can divide 
infinitely due to expression of telomerase (hTERT). A significantly higher percent of 
myofibroblasts was observed in hTERT cells (p < 0.001), and treatment with 
transforming growth factor-β1 produced significantly more myofibroblasts in all three 
cell ages (p<0.001) when cells were plated on coverslips that provided immediate 
tension. However, in an environment where tension was not immediate, but developed 
over time, myofibroblast formation and contraction was limited in all cell ages. Migration 
of fibroblasts was not significantly affected by cell age or presence of telomerase. The 
addition of telomerase increased myofibroblast formation, limited their contraction and 
had no effect on their migration, but may have increased proliferation rates. Overall, the 
results showed that replicative senescence did not have an effect on myofibroblast 
formation or migration, but could affect contraction rate.  
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INTRODUCTION 
 
Background  
The skin is the largest organ of the body and it provides protection, temperature 
regulation, signal reception, and help with excretion and/or absorption of substances 
(Gartner and Hiatt, 2007). It can be divided into two main layers: the epidermis, 
composed of stratified squamous keratinized epithelial cells; and the dermis, composed of 
collagen, elastic fibers and various cells such as fibroblasts, mast cells, lymphocytes, 
macrophages and fat cells. In the dermal layer, fibroblasts are the most abundant cells. 
They are responsible for making, organizing, and maintaining many components in the 
extracellular matrix (ECM), such as collagen fibers that allow cells to anchor themselves 
for movement (Grinnell, 2003). Organization and maintenance of the ECM help to 
maintain the shape and elasticity of the skin and contribute to distinguishing features such 
as fingerprints (Gartner and Hiatt, 2007), while degradation of the ECM can result in 
wrinkling of the skin (West, 1994). This intricate organization also allows for the 
dynamic series of events that occurs when the skin’s protective ability has been 
compromised by a wound. When the skin has been wounded, a blood clot creates a 
temporary seal and provides a provisional ECM upon which cells can move (Singer and 
Clark, 1999). Fibroblasts are important in the next phase of wound healing as they 
proliferate and migrate into the wounded area (Clark, 1989; Genever et al., 1993; Singer 
and Clark, 1999) while synthesizing collagen and fibronectin for the new ECM (Clark, 
1989). As migration continues, the fibroblasts reorganize the ECM along lines of stress 
that provide mechanical tension for the cell (Tomasek et al., 2002). When this tension is 
present, the fibroblast can differentiate into a proto-myofibroblast, characterized by 
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cytoplasmic actin fibers and demonstrating limited contractile force. Stimulated by 
growth factors produced by platelets (Assoian et al., 1983) and cells present in the blood 
clot, further differentiation creates a myofibroblast that can generate a greater contractile 
force, thereby allowing the wound to fully close (Tomasek et al., 2002). Myofibroblasts 
have generally been characterized by the presence of α-smooth muscle actin (α-sma) 
stress fibers similar to those fibers found in smooth muscle cells (Skalli et al., 1986; 
Darby et al., 1990). These fibers help increase force and develop tension, allowing 
enough contraction for a wound to completely close. The presence of the cytokine 
transforming growth factor –β1 (TGF-β1), naturally produced by platelets, can induce 
this change by increasing the formation of structural elements such as stress fibers, as 
well as focal adhesions that contain proteins such as vinculin (Vaughan et al., 2000). 
Finally, TGF-β1 contributes to the production of α-sma (Desmouliere et al., 1993; 
Desmouliere, 1995; Vaughan et al., 2000). There is limited in vivo data about human 
wound healing. However, in rats TGF-β levels spike shortly after a wounding event, 
usually within an hour, and then again five days later, demonstrating its importance to 
wound healing (Yang et al., 1999). Regulation of TGF-β1 production is done by the 
molecule itself. While TGF-β1 stimulates several factors that are important for a wound 
to heal, its deposition of the ECM components at a wound site could also be the cause of 
scarring and fibrosis (Border and Ruoslahti, 1992; Martin, 1997).  
 Wound healing is further complicated with age and tends to be decreased in older 
individuals (Ashcroft et al., 2002); therefore there is great interest in how cellular aging 
may contribute to this difference. Most cells have a limited lifespan and exhibit 
reproductive and structural changes as they age. Aging of a cell can result from intrinsic 
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genetic or biological factors or from extrinsic oxidative stress from environmental factors 
such as UV radiation (Vaughan et al., 2004). Regardless, as fibroblast cells age, they 
show an increase in the organization of their cytoskeletal components (Wang and 
Gundersen, 1984). Microtubule organization centers are amplified in late passage (LP) 
fibroblasts and 10-nm filaments that encircle the nuclei in early passage (EP) fibroblasts 
appear to become tightly packed in the perinuclear region of LP cells. Actin fibers that 
are usually fewer in number and scattered in EP cells become greater in number and 
heterogeneously distributed in LP cells. Cell proliferation or reproduction in EP cells can 
be characterized by logarithmic growth that eventually slows and then stops as the cell 
becomes an LP cell (West, 1994). When a cell reaches a point when it will no longer 
divide it is termed senescent (Hayflick and Moorhead, 1961). The number of senescent 
cells in mitotic tissue of primates has been shown to increase with the age of an 
organism. In younger baboons, 3% of dermal fibroblasts showed signs of senescence 
whereas 30% of the fibroblasts were senescent in older baboons (Jeyapalan et al., 2007). 
The number of times a cell can divide before becoming senescent varies depending on 
species and genetic makeup, and a possible process that limits proliferation based on the 
number of times a cell divides is termed replicative senescence (Campisi, 1997). There is 
evidence that replicative senescence plays a role in organismal aging. Cells from older 
donors do not undergo as much proliferation, and show higher senescence-associated 
markers and decreased telomere length (Jeyapalan and Sedivy, 2008). The ability to 
perform wound contraction necessary for healing can also change over the life of a cell. 
There is conflicting evidence about the effects of age on the cell’s ability to contract as 
demonstrated by studies that have shown that as a cell ages, its contraction ability  
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increases (Gibson et al., 1989), whereas others have shown that the ability to contract 
decreases (Bell et al., 1979; Kono et al., 1990; Yamato et al., 1992). The changes in the 
structure of the ECM as aging occurs can affect the cell’s ability to contract as aged 
fibroblasts do not synthesize as much collagen as younger cells (Varani et al., 2006). In 
the dermis of aged skin, the collagen matrix upon which fibroblasts attach is fragmented 
and there is an increase in collagen-degrading matrix metalloproteinases-1 (MMP-1) 
(Fisher et al., 2008; Fisher et al., 2009). Collagen fragmentation makes it difficult for a 
fibroblast to anchor itself to create tension and under such conditions the fibroblast 
collapses. In this collapsed state, the fibroblasts produce lower levels of collagen and 
higher levels of enzymes, like collagenase, that degrade collagen even further. Similarly, 
fibroblasts that are triggered to become senescent, possibly due to a decrease in telomere 
length, lose their ability to initiate proliferation and increase the production of 
collagenase (West, 1994). The increase in senescent cells in aging skin may play a role in 
delayed wound healing, especially when the absolute number of cells in aging skin is 
decreased (Ashcroft et al., 2002).   
 One of the more prominent views on what controls the process of replicative 
senescence is the length of telomeres (Wright and Shay, 2002). Telomeres are non-coding 
sections of repeating TTAGGG nucleotide sequences and specific proteins (Cristofalo et 
al., 2004; Boukamp, 2005; Shay and Wright, 2007). Each time a cell divides, a small 
portion of the lagging strand of DNA cannot be replicated, causing the telomere to 
shorten. Continued replication and telomere shortening will lead to growth arrest or 
replicative senescence when the telomeres finally become too short. Average telomere 
lengths have been quantified using PCR techniques (Harley et al., 1990). In neonate 
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dermal fibroblasts, the average length of telomeres was 10 kbp while only 5 kbp when 
they became senescent; comparing samples from many ages of donors, an inverse 
relationship between telomere length and age has been found (Lindsey et al., 1991; 
Slagboom et al., 1994). Non-human primates, such as spider, squirrel and Rhesus 
monkeys, along with orangutans and pigmy chimpanzees, also show this inverse 
relationship between telomere length and age (Steinert et al., 2002). These observations 
correlate with the demonstrated increase of senescent cells in primate tissues (Jeyapalan, 
2007) suggesting that a similar phenomenon would be expected in human tissues as aging 
occurs. When comparing the initial telomere length in human fibroblasts to the number of 
times the population can divide, there is a strong correlation of replicative capacity to cell 
age (Allsopp et al., 1992). The shorter the initial telomere, the fewer times the population 
could double before becoming senescent. An inverse correlation has also been found 
between the average telomere length and the age of other cells, such as white blood cells 
(Cawthon et al., 2003; Kimura et al., 2007). The incidence of certain age-related 
disorders also has been correlated to the length of telomeres. Shorter telomeres have been 
found in endothelial cells of patients with coronary artery disease (Ogami et al., 2004) 
and Alzheimer’s patients had short telomeres in their T cells (Panossian et al., 2003). 
Skin fibroblasts in baboons showed an increase in telomere dysfunction with an increase 
in age when analyzed for biomarkers of cellular senescence such as telomere 
dysfunction-induced foci (Herbig et al., 2006).  
In cells that proliferate continuously, such as stem cells, germ cells and many 
tumor cells, telomere shortening can be overcome by the up-regulation of the enzyme 
telomerase. Telomerase is composed of a telomerase RNA component (TERC) and 
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telomerase reverse transcriptase (TERT; hTERT when referring to human), together 
creating a complex that can add replicates of the DNA sequence TTAGGG to the ends of 
telomeres (Shay and Wright, 2007). Experiments have shown that telomerase can 
circumvent the effects of replicative senescence (Holt et al., 1996; Funk et al., 2000). 
Cells transduced with hTERT are termed immortal due to their infinite ability to replicate 
(Hornsby, 2007). Understanding the mechanisms of replicative senescence and the effects 
of telomerase could lead to a variety of treatments for aging disorders (Hornsby, 2007) as 
well as treatments for various cancers (Shay and Wright, 2007).  
Objectives 
This study was designed to evaluate the consequences of replicative senescence 
on fibroblasts in terms of myofibroblast formation, contraction and rate of migration, all 
of which play an important role in wound healing. Previously mentioned studies have 
shown differences in the behavior of cells as they age (Bell et al., 1979; Wang and 
Gundersen, 1984; Gibson et al., 1989;  Kono et al., 1990; Yamato et al., 1992; West, 
1994; Ashcroft et al., 2002; Jeyapalan et al., 2007; Varani et al., 2006), whereas others 
have studied the events of wound healing and factors that can affect that process (Skalli 
et al., 1986; Clark, 1989; Darby et al., 1990; Border and Ruoslahti, 1992; Desmouliere et 
al., 1993; Genever et al., 1993; Desmouliere, 1995; Martin, 1997; Singer and Clark, 
1999; Yang et al., 1999; Vaughan et al., 2000; Tomasek et al. 2002). The models used in 
this study investigated the physiological and morphological changes in aging fibroblasts 
in vitro, and evaluated how these changes may play a role in the three major functions of 
fibroblasts in the wound healing process. This study also evaluated the effects of 
telomerase (referred to as hTERT) to determine if the addition of this enzyme to late 
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passage cells could immortalize these cells, and then determine whether this can change 
the replicative senescence phenotype with regard to cellular contraction, migration, and 
ability to form myofibroblasts.  The null hypothesis was that there will be no difference 
among the three cell ages (early passage, late passage, and hTERT) in the percent of 
myofibroblasts, the ability to contract or migration time. The alternate hypothesis was 
that there will be a difference among the cell ages in the percent of myofibroblasts, the 
ability to contract or migration time.  
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MATERIALS AND METHODS 
 
Cell cultures  
 
 IRB approval was obtained prior to experimental procedures (UCO IRB #09083). 
Fibroblasts were received from the University of Oklahoma Health Sciences Center 
(OUHSC) where they were isolated from tissues obtained from patients undergoing 
Carpal Tunnel release; for these studies cells were obtained from the 4
th
 donor (CT4). 
When the tissue was placed in a culture dish, fibroblasts migrated out of the tissue and 
were isolated.  The in vitro age (described as the average number of replications, or 
population doublings, per cell population) of the CT4 cells at this point was considered 
zero. The hTERT cells were transduced at OUHSC by incorporating the hTERT gene 
into viral particles that incorporated the gene into its hosts’ DNA along with an antibiotic 
resistance vector (pBABE puromyocin). Selection of the transduced hTERT cells was 
performed by growing them in the presence of puromycin until untransduced cells were 
killed. When the cells were received from OUHSC, they were cultured in Dulbecco’s 
Modified Eagle’s Medium (DMEM, Sigma) + 10% Fetal Bovine Serum (FBS) + 
penicillin/streptomycin/amphotericin (ABAM, Sigma) and kept incubated in tissue 
culture dishes (100 x 20 mm, Fisher) at 37
o
C at 5% CO2 with high humidity. Cells were 
subcultured at least once every seven days to keep them from becoming quiescent, a 
reversible state of nondivision. 
 To determine cell concentration, cells were counted on a cell counting chamber 
(hemocytometer) prior to each experiment. Then the appropriate amount of cell solution 
was added to media to obtain the desired concentration for each test. The age of the cells 
was determined (each time the cells were subcultured) by calculating how many times the 
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population had doubled (PD). The total number of cells in the culture dish was 
determined and then divided by the number of cells originally plated in the dish. The log 
of this number was divided by 0.3 and the resulting figure was added to the starting PD. 
CT4 cells usually survive in culture to a PD of ~45 (Vaughan MB, personal 
communication, June 5, 2009). This study evaluated three ages of cells: early passage 
cells (EPD) with a PD of less than 20, late passage cells (LPD) with a PD greater than 30 
(approaching senescence), and hTERT cells with a PD greater than 30 to ensure that a 
true comparison could be made between LPD and hTERT in order to assess the ability of 
telomerase to overcome the effects of aging. 
 Telomere length was not measured in this study. Because studies have shown that 
telomeres shorten as a cell ages (for review, Shay and Wright, 2007), it was inferred that 
the telomeres in the LPD cells were shorter than the EPD cells. Studies have also shown 
that expression of telomerase can lengthen telomeres (Bodnar et al., 1998) so it was 
assumed that due to the increased telomerase, the hTERT cells were not subject to 
telomere shortening.  
Coverslips  
 
 Glass coverslips (12mm round, Fisher Scientific), 12 for each cell age, were 
placed into wells in a 24 well spot plate (Falcon Multiwell). A cell concentration of 
3.0x10
4
 cells was placed in each well with a coverslip, and 1µL of either TGF-β1 or a 
vehicle (0.1% bovine serum albumin (BSA) in 1X phosphate buffer solution (PBS)) was 
added to each of the wells (Figure 1a). Cells were incubated at 37
o
C for two days. This 
incubation period allowed time for α-sma to form while limiting the time for cell 
proliferation. After incubation, coverslips were fixed using methanol at -20
o
C for five  
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Figure 1. Experimental design. 
a. Setup for coverslips provided six replicates in each treatment group for each cell age. 
b. Each collagen lattice design yielded twelve replicates for contraction data (each circle 
represents two replicates) and two replicates for staining for each cell age. c. Each 
scratch assay yields three replicates, and two assays were done for each cell age.  
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minutes, rinsed with 1X PBS, and stored in 1X PBS + 0.02% azide until staining. 
 For each cell age, six coverslips from each treatment group were stained for α-
sma using indirect immunofluorescence. The primary antibody used was a mouse anti-α-
sma monoclonal antibody (1:500 dilution, clone 1A4, Sigma®). The secondary antibody 
was goat anti-mouse rhodamine (1:200 dilution, Molecular Probes®). Coverslips were 
also stained with 4’, 6-diamidino-2-phenylindole HCL (DAPI) to visualize the nuclei. 
Coverslips were then mounted on a microscope slide using 80% glycerol. Each slide was 
viewed with an Olympus BX-41 microscope equipped with epifluorescence and a digital 
camera linked to diagnostic software (SPOT DiagnosticsTM).  Using ten to twelve 
different fields of view on each coverslip, cells were photographed and quantified as α-
sma positive or negative (Figure 2). The percentage of myofibroblasts (positive cells) 
from all fields was determined for each of the six coverslips. The data were then 
transformed by determining the arcsine of the square root of each percentage. This 
transformation created more normally distributed data allowing the use of a two-way 
ANOVA (SigmaPlot 11.0®) to analyze the effects of age and TGF-β1 individually and 
together. The alpha level was set at 0.05 with degrees of freedom of 35 (n-1, where n = 
(ages of cells) (groups with or w/o TGF-β1) (replicate means) or (3) (2) (6) =36). Then a 
Fisher LSD test was used to determine significant pairwise differences among groups. 
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control 
EPD 
 
 TGF-β 
EPD 
 
control 
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control 
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 TGF-β 
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Figure 2. Representative microscopic images to quantify data from stained 
coverslips. Coverslips were stained with DAPI to visualize and thereby quantify the 
number of nuclei (cells) in the field
stress fibers associated with the myofibroblast phenotype. When the two photos 
were merged, the number of myofibroblasts 
were associated with stress fibers. 
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Collagen lattices  
 
 Cells were mixed into type I collagen (Biocoat; Becton Dickinson) so that the 
final collagen concentration was 0.69 mg/mL and the final concentration of cells was 
1.25 x 10
5
 cells/mL. A 250 µL drop of the collagen/cell mixture was plated onto 40 mm  
tissue culture dishes (Techno Plastic Products) and incubated at 37
o
C for one hour to 
allow the solution to solidify and adhere to the dish. At that time, 2 mL of media (DMEM 
+ 10% FBS + ABAM) with either 1 µL of TGF-β1 or a vehicle (0.1% BSA in 1X PBS) 
was added to each dish. Dishes were incubated for 2 days to allow α-sma formation with 
limited proliferation. This incubation time also allowed the fibroblasts to reorganize the 
lattice and create tension (Tomasek et al., 1992). For each cell age, 28 dishes were 
prepared (Figure 1b). Fourteen of the 28 dishes were treated with TGF-β1 and 14 with the 
vehicle (0.1% BSA in 1X PBS). Twelve from each treatment group were released 
(detached from the dish) and measured. The remaining two lattices from each treatment 
were preserved in 4% paraformaldehyde (Ultrapure EM Grade, Polysciences®), 
immersed in 0.25% triton to permeabilize the cell membranes, then stained for α-sma as 
described with coverslips. Once stained, cells were then identified as α-sma positive or 
negative and the percentage of myofibroblasts was determined (Figure 3). The data were 
then transformed by determining the arcsine of the square root of each percentage. This 
transformation created more normally distributed data allowing the use of a two-way 
ANOVA (SigmaPlot 11.0®) to analyze the effects of age and TGF-β1 individually and 
together. The alpha level was set at 0.05 with degrees of freedom of 11 (n-1, where n = 
(ages of  
Figure 3. Representative microscopic images to quantify data from stained 
lattices. Cells were stained with 
They were also stained for α
myofibroblast pheno
positive and nuclei with no distinct stress fibers were counted as negative. 
DAPI 
EPD 
Control 
 EPD 
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LPD 
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DAPI to visualize and count nuclei (cells). 
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cells) (groups with or w/o TGF-β1) (replicate means) or (3) (2) (2) = 12). A Fisher LSD 
test was used to determine significant pairwise differences among groups. 
   Before releasing a lattice, the initial diameter of the collagen lattice was measured 
by placing the dish on a ruler and reading it through a Baush & Lomb stereoscope. The 
lattice was gently lifted at the edge using a probe and then completely released from the 
dish by pipetting media underneath the loose edge (Tomasek et al., 1992). The diameter 
of the lattice was recorded at 2, 10, 30 and 60 minutes after release. Due to the variability 
of the initial lattice diameters, the relative diameter change was used for data comparison 
and was calculated by dividing the diameter of the lattice at each time point by the initial 
diameter of the lattice. For each cell age, data were collected from twelve lattices of each 
treatment group and were analyzed using a two-way ANOVA (SigmaPlot 11.0®) on each 
of the time points (2, 10, 30, 60 minutes). Alpha level was set at 0.05 and degrees of 
freedom of 71 (n-1, where n = (ages of cells) (groups with or w/o TGF-β1) (replicates) or 
(3) (2) (12) = 72). A Fisher LSD test was used to determine significant pairwise 
differences among groups. 
Scratch Assay  
 
 Cells were plated in tissue culture dishes (TPP 40 mm) and allowed to become 
greater than 90% confluent (Denker and Barber, 2002). On the bottom of the plate, a 
reference line was drawn across the diameter and three scratches were made 
perpendicular to the line with a 200µL pipet tip (Figure 4). This was done with two 
dishes to yield six replicates. Photographs of each scratch were taken above or below the 
reference line at 0, 12, 18 and 24 hours. Each photograph was then used to determine the 
area of the wound at that time by drawing a line around the perimeter of the open wound  
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Figure 4. Photographs of the initial wound of scratch assays. 
Subsequent photos are not displayed since reduction in the size of the 
image does not provide clarity of the cells or wound edges. Area of the 
wound was measured as the open wound area that occurs from the 
reference line out to 0.5 mm.   
reference 
line 
 0.5   
 mm 
Area of 
wound 
hTERT 
EPD 
LPD 
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area and calculating that area (mm
2
) using ImageJ software. The wound area was defined 
starting at the reference line and moving 0.5 mm out from that point to ensure similar 
areas were being measured (Figure 4). For all three cell ages, the relative decrease in the 
area at each time marker was analyzed using a two-way ANOVA (SigmaPlot 11.0®). 
The alpha level was set at 0.05 with degrees of freedom of 53 (n-1, where n = (ages of 
cells) (time periods) (replicates) or (3) (3) (6) = 54). A Fisher LSD test was used to 
determine significant pairwise differences among groups. 
 
Cell Count 
 
 In the collagen lattice and coverslip tests, proliferation may affect the results 
(Vaughan et al., 2000; Tomasek et al., 1992). While analyzing the tests, the number of 
cells counted was recorded, as well as the number of different field of views (fov) 
analyzed. While this did not give a specific cell concentration, a comparison of the 
average number of cells per fov was used to determine whether any group had a larger 
mean number of cells.  The mean number of cells per fov was analyzed using a two-way 
ANOVA (SigmaPlot 11.0®). For coverslips, the alpha level was set at 0.05 with degrees 
of freedom of 35 (n-1, where n = (ages of cells) (treatment groups) (replicates) or (3) (2) 
(6) = 36). For collagen lattices, the alpha level was set at 0.05 with degrees of freedom of 
11 (n-1, where n = (ages of cells) (treatment groups) (replicates) or (3) (2) (2) = 12). A 
Fisher LSD test was used to determine significant pairwise differences among groups. 
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 RESULTS 
 
Coverslips 
Percentage of Myofibroblasts  
 Of the early passage cells (EPD) in the control group, 26.2% were myofibroblasts 
as compared to 71.9% in the TGF-β group (Figure 5). Of the late passage cells (LPD) in 
the control group, 25.6% were myofibroblasts compared to 63.8% in the TGF- β group. 
Of the cells transduced with telomerase (hTERT), 80.5% were myofibroblasts in the 
control group and 93.9% in the TGF-β group. Raw data can be found in the Appendix. 
A Shapiro-Wilk test for normality and a test for equality of variances was run. A p 
value of greater than 0.05 indicates that data are distributed normally and variance in the 
groups are equal. Both normality (p = 0.524) and equality (p = 0.149) were found. A two-
way analysis of variance (ANOVA) was conducted to evaluate the effects of cell age and 
TGF-β1 treatment on the development of myofibroblasts. The levels of cell age were 
early population doubling (EPD), late population doubling (LPD), and the cells 
transduced with telomerase (hTERT). The levels of treatment were no treatment (control) 
and TGF-β1 treatment (TGF). Significant differences were found among cell ages 
F(2,30) =41.092, p < 0.001, and drug treatment, F(1,30) = 59.224, p < 0.001. A 
significant interaction was found between the cell age and treatment, F(2,30) = 3.512, p = 
0.043 (Table 1). 
Fisher LSD across-group tests showed a significant difference between the 
percent of myofibroblasts present in the control group between hTERT and EPD (p < 
0.001) and hTERT and LPD (p < 0.001). The hTERT cells had significantly higher 
percentages of myofibroblasts than both EPD and LPD. There was not a significant  
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Figure 5. Percentage of myofibroblasts found on coverslips. In all three cell ages, 
there was a larger percentage of myofibroblasts found in the TGF-β groups. 
Among the control groups, EPD and LPD cells maintained a similar number of 
myofibroblasts whereas the hTERT cells were significantly higher. A similar 
trend appeared in the TGF-β groups, with the hTERT cells having more 
myofibroblasts than the EPD and LPD cells. Bars with the same letter are not 
significantly different. 
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Table 1. Two-way ANOVA results table for myofibroblast formation 
on coverslips. A P value less than 0.05 shows significance. There was a 
significant difference in the cell ages, as well as the experimental 
groups. A Fisher LSD test shows among cell ages, the hTERT cells 
were different from the EPD and LPD cells, and the TGF-β groups 
were different from the control groups.  
Source of variation DF SS MS F P 
Cell Age 2 1.749 0.875 41.092 <0.001 
Treatment Group 1 1.261 1.261 59.224 <0.001 
Cell Age x Treatment 2 0.150 0.0748 3.512 0.043 
Residual 30 0.6.9 0.0213   
Total 35 3.798 0.109   
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difference in percentage of myofibroblasts in the control group between EPD and LPD, 
(p=.928).   
These same differences were found in the TGF-β1 groups using Fisher LSD 
across-group treatment tests. There were significant differences in the percentage of 
myofibroblasts between the hTERT and EPD (p < 0.001) and hTERT and LPD (p = 
0.002). The hTERT cells again had significantly higher percentages of myofibroblasts 
then EPD and LPD. There was not a significant difference between EPD and LPD (p = 
0.226).  
Fisher LSD within-group tests showed a significant difference for treatment in all 
cell ages, EPD (p < 0.001) LPD (p < 0.001), and hTERT (p = 0.05). All three cell ages 
had a significant increase in number of myofibroblasts when given TGF- β1 (Figure 5).  
Cell Count 
When quantifying EPD cells within the control group, 712 cells were counted 
within 72 different fields of view (fov) from 6 coverslips yielding a mean of 9.89 
cells/fov (Figure 6). Within the EPD TGF-β group, 713 cells were counted in 72 fov from 
6 coverslips yielding a mean of 9.90 cells/fov. When quantifying LPD cells within the  
control group, 748 cells within 72 different fov from 6 coverslips gave a mean of 10.39 
cells/fov. Within the LPD TGF-β group, 687 cells were counted in 72 fov from 6 
coverslips giving a mean of 9.54 cells/fov. When quantifying hTERT cells within the  
control group, 1023 cells within 60 different fov from 6 coverslips gave a mean of 17.05 
cells/fov. Within the hTERT TGF-β group, 891 cells were counted in 60 fov from 6 
coverslips giving a mean of 14.85 cells/fov. Raw data can be found in the Appendix. 
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Figure 6. Effect of cell age and treatment on mean number of cells on coverslips. All 
coverslips were originally plated with the same concentration of cells (0.30 x 10
5
 
cells). Proliferation effects were estimated by comparing the mean number of cells 
per field of view observed. EPD and LPD coverslips maintained similar cell counts 
whereas hTERT cells had a higher number of cells. Bars with the same letter are not 
significantly different. 
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  A two-way ANOVA was conducted to evaluate the effects of cell age and TGF-
β1 treatment on the total number of cells present. The levels of cell age were early 
population doubling (EPD), late population doubling (LPD), and the cells transduced 
with telomerase (hTERT). The levels of treatment were no treatment (control) and TGF-
β1 treatment (TGF). A significant difference was found for the main effect of cell age, 
F(2,30) = 20.37, p < 0.001. The sub effect of TGF- β1 treatment was not significant, 
F(1,30) =1.293, p = 0.0264. No interaction was found between cell age and TGF- β1 
treatment, F(2,30) = 0.525, p = 0.597 (Table 2). 
 Fisher LSD across-group tests showed a significant difference in cell number 
between hTERT and the EPD, (p < 0.001) and the hTERT and LPD (p < 0.001). There 
was a significantly greater number of hTERT cells present than EPD and LPD cells. The 
EPD and LPD were not significantly different (p = 0.950) (Figure 6). 
 
Collagen Lattices 
Percentage of Myofibroblasts 
Non released lattices were stained after two days and then analyzed for 
myofibroblasts by counting the number of nuclei in a field of view then correlating them 
to stress fibers. The percentage of cells positive for α-sma in the EPD lattices was 1.2% 
in the control group and 2.1% in the TGF-β group (Figure 7). In the LPD lattices there 
were 0.9% in the control group and 1.6% in the TGF-β group. There were 3.1% in the 
hTERT control group versus 3.2% in the hTERT TGF-β group. Raw data can be found in 
the Appendix. 
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Table 2. Two-way ANOVA table for cell number on coverslips. A P 
value less than 0.05 shows significance. There was a significant 
difference among cell ages but no significant difference between the 
treatment groups. No significant interaction occurred. A Fisher LSD test 
shows that among the cell ages, the number of hTERT cells was 
significantly higher than the EPD and LPD cells. 
Source of variation DF SS MS F P 
Cell Age 2 289.899 144.949 20.370 <0.001 
Treatment Group 1 9.201 9.201 1.293 0.264 
Cell Age x Treatment 2 7.473 3.736 0.525 0.597 
Residual 30 213.470 7.116   
Total 35 520.043 14.858   
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Figure 7. Percentage of myofibroblasts in collagen lattices. 
Myofibroblast formation was limited in all three cell ages 
regardless of treatment group and there was no significant 
difference among any of the groups. 
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A two-way ANOVA was conducted to evaluate the effects of cell age and TGF-β1 
treatment on the development of myofibroblasts. The levels of cell age were early 
population doubling (EPD), late population doubling (LPD), and the cells transduced 
with telomerase (hTERT). The levels of treatment were no treatment (control) and TGF-
β1 treatment. No significant differences were found in either the cell ages, F(2,6) = 1.892, 
p = 0.231, or the treatment, F(1,6) = 0.756, p = 0.418. Nor was a significant interaction 
found, F(2,6) = 0.272, p = 0.771 (Table 3). 
Cell Count 
The mean number of cells per field of view (fov) was also calculated for the 
unreleased collagen lattices (Figure 8). In the EPD control group, 366 cells were counted 
from 10 fov from two lattices yielding a mean of 36.6 cells/fov whereas the TGF-β group 
had 321 cells in 10 fov from two lattices for a mean of 32.1 cells/fov. The LPD control 
group had 256 cells counted in 10 fov from two lattices with a mean of 25.6 cells/fov and 
278 cells in 10 fov from two lattices giving a mean of 27.8 cells/fov in the TGF-β group. 
In the hTERT control group, there were 608 cells counted in 10 fov from two lattices to 
yield a mean of 60.8 cells/fov and 594 cells in 10 fov from two lattices for the TGF-β 
group giving them a mean of 59.4 cells/fov. Raw data can be found in the Appendix. 
A two-way ANOVA was conducted to evaluate the effects of cell age and TGF-
β1 treatment on the total number of cells present. The levels of cell age were early 
population doubling (EPD), late population doubling (LPD), and the cells transduced 
with telomerase (hTERT). The levels of treatment were no treatment (control) and TGF-
β1 treatment (TGF). No significant differences were found in either the cell  
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Table 3. Two-way ANOVA table for collagen lattice myofibroblast 
formation. None of the groups have a P value of less than 0.05; therefore 
there were no significant differences and no interaction. 
Source of Variation DF SS MS F P 
Cell Type 2 0.00950 0.00475 1.892 0.231 
Exp. Group 1 0.00190 0.00190 0.756 0.418 
Cell Type x Exp. Group 2 0.00136 0.000682 0.272 0.771 
Residual 6 0.0151 0.00251   
Total 11 0.0278 0.00253   
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Figure 8. Effect of cell age and treatment on number of cells in collagen lattices. 
All collagen lattices were originally plated with the same concentration of cells 
(1.25 x 10
5
 cells). Proliferation effects were estimated by comparing the mean 
number of cells per field of view observed. EPD and LPD lattices maintained 
similar cell counts whereas hTERT lattices had a higher number of cells. Bars with 
the same letter are not significantly different. 
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ages, F(2,6) = 1.982, p = 0.218, or the treatment, F(1,6) = 0.501, p = 0.506, nor was a 
significant interaction found, F(2,6) = 0.0901, p = 0.915 (Table 4).  
Contraction of Lattices    
Contraction of lattices was recorded for collagen lattices that were released from the 
tissue culture dish. Contractions were recorded at 0, 2, 10, 30 and 60 minute intervals 
after lattices had been released from the culture dish (Figure 9). Raw data can be found in 
the Appendix. A two-way ANOVA was run at each of the time intervals to determine the 
effects of cell ages and treatment.  
The two-way ANOVA for the two-minute time interval showed significance for 
the main effect of cell age, F(2,66) = 7.874, p < 0.001 (Table 5). No significance was 
found for the sub effect of TGF-β1 treatment, F(1,66) = 0.421, p = 0.519. A significant 
interaction was found between cell age and treatment, F(2,66) =14.934, p < 0.001. This 
interaction was due to differences in the treatment factor on lattice contraction of cells of 
different ages. The EPD cells had greater lattice contraction in the control group while 
the hTERT cells showed greater contraction in the TGF-β1group. The LPD cells showed 
no difference based on treatment. 
Fisher LSD across-group tests for the main effect of cell age showed a significant 
difference in lattice contractions between LPD and the hTERT (p = 0.002) and the LPD 
and EPD (p < 0.001). There was a significantly greater lattice contraction for both the 
EPD and hTERT cells when compared to the LPD cells. The EPD and hTERT cells were 
not significantly different (p = 0.705). 
The two-way ANOVA for the ten-minute time interval showed a significance for 
the main effect of cell age, F(2,66) = 15.919, p < 0.001 (Table 6). No significance was  
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Table 4. Two-way ANOVA table for cell number in collagen lattices. A 
P value less than 0.05 shows significance. None of the groups have a P 
value of less than 0.05; therefore there were no significant differences 
and no interaction. 
Source of variation DF SS MS F P 
Cell Age 2 7.523 3.762 1.982 0.218 
Treatment Group 1 0.951 0.951 0.501 0.506 
Cell Age x Treatment 2 0.342 0.171 0.0901 0.915 
Residual 6 11.39 1.898   
Total 11 20.206 1.837   
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Figure 9. Effect of cell age on lattice contraction in the presence or absence of TGF-β. 
Lattice contraction graphs showing relative lattice diameter for 2, 10, 30, and 60 
minute intervals. Overall the LPD cells contracted the most, followed by the EPD cells 
and then hTERT cells contracting the least. In lattices with EPD and LPD cells, the 
control group contracted more than the TGF-β group, whereas in lattices with hTERT 
cells, the control group contracted less.   
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Table 5. Two-way ANOVA table for collagen lattice contraction at 2 
minutes. A P value less than 0.05 shows significance. There was a 
significant difference among cell ages but not between treatment 
groups. There was a significant interaction between cell age and 
treatment group. A Fisher LSD test showed the lattices with LPD cells 
were significantly different from the lattices with EPD and hTERT 
cells. 
Source of variation DF SS MS F P 
Cell Age 2 0.00633 0.00316 7.874 <0.001 
Treatment Group 1 0.00016 0.00016 0.421 0.519 
Cell Age x Treatment 2 0.0120 0.00600 14.934 <0.001 
Residual 66 0.0265 0.00040   
Total 71 0.0450 0.00063   
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Table 6. Two-way ANOVA table for collagen lattice contraction at 10 
minutes. A P value less than 0.05 shows significance.  There was a 
significant difference among cell ages but not treatment groups. There 
was a significant interaction between cell age and treatment group. A 
Fisher LSD test showed the lattices with EPD cells were significantly 
different from the lattices with LPD and hTERT cells. 
Source of variation DF SS MS F P 
Cell Age 2 0.160 0.0799 15.919 <0.001 
Treatment Group 1 0.00786 0.00786 1.566 0.215 
Cell Age x Treatment 2 0.121 0.0607 12.088 <0.001 
Residual 66 0.331 0.00502   
Total 71 0.620 0.00874   
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found for the sub effect of TGF-β1 treatment F(1,66) = 1.566, p = 0.215. A significant 
interaction was found between cell age and treatment, F(2,66) =12.088, p < 0.001. This 
interaction was again due to differences in the treatment factor on lattice contraction of 
cells of different ages. The EPD cells had greater lattice contraction in the control group 
while the hTERT cells showed greater contraction in the TGF-β1 group. The LPD cells 
showed no difference based on treatment. 
Fisher LSD across-group tests for the main effect of cell age showed a significant 
difference in lattice contractions between EPD and hTERT (p < 0.001) and the EPD and  
LPD (p < 0.001). There was a significantly greater lattice contraction for both the LPD 
and hTERT cells when compared to the EPD cells. The LPD and hTERT cells were not 
significantly different (p = 0.705). 
The two-way ANOVA for the thirty-minute time interval showed a significance 
for the main effect of cell age, F(2,66) = 17.326, p < 0.001, and the sub effect of TGF-β1 
treatment F(1,66) = 5.606, p = 0.021 (Table 7). A significant interaction was also found, 
F(2,66) = 11.274, p < 0.001. This interaction was due to differences in the treatment 
factor on lattice contraction of cells of different ages. The EPD and LPD cells had greater 
lattice contraction in the control group while the hTERT cells again showed greater 
contraction in the TGF-β1 group.  
Fisher LSD across-group tests for the main effect of cell age showed a significant 
difference in lattice contractions between EPD and hTERT, (p = 0.004), EPD and LPD (p 
< 0.001) and LPD and hTERT (p = 0.005). The LPD cells showed the greatest lattice 
contraction followed by the hTERT cells and then the EPD cells. 
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Table 7. Two-way ANOVA table for collagen lattice contraction at 30 
minutes. A P value less than 0.05 shows significance. There was a 
significant difference in cell ages and in treatment groups. There was a 
significant interaction between cell age and treatment group. A Fisher 
LSD test showed lattices with all three cell ages were significantly 
different from each other.  
Source of variation DF SS MS F P 
Cell Age 2 0.0341 0.0171 17.326 <0.001 
Treatment Group 1 0.00552 0.00552 5.606 0.021 
Cell Age x Treatment 2 0.0222 0.0111 11.274 <0.001 
Residual 66 0.0650 0.00098   
Total 71 0.127 0.00179   
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The two-way ANOVA for the sixty-minute time interval showed a significance 
for the main effect of cell age, F(2,66) = 16.114, p < 0.001 (Table 8). No significance was 
found for the sub effect of TGF-β1 treatment F(1,66) = 0.653, p = 0.422. The interaction 
was not significant, F(2,66) = 0.423, p = 0.657.  
Fisher LSD across-group tests for the main effect of cell age showed a significant 
difference in lattice contractions between LPD and the hTERT (p < 0.001) and the LPD 
and EPD (p < 0.001). There was a significantly greater lattice contraction for the LPD 
cells than both the EPD and hTERT cells. The EPD and hTERT cells were not 
significantly different.  
The interaction between cell age and treatment at three time points could be 
attributed to the differing effects of the treatment in different cell ages. The EPD lattices 
in the control group contracted significantly more at every time point when compared to 
the EPD lattices in the TGF-β1 group except for the 60-minute mark. The LPD lattices 
showed a similar trend having more contraction from the control group at the 10 and 30 
minute time points. However, the hTERT lattices showed more contraction at every time 
point from the TGF-β group rather than from the control group at all but the 60 minute 
time period.  
 The absence of an interaction at 60 minutes and the lack of significance for the 
sub effect of treatment across all time intervals, except the 30-minute point, indicate the 
main effect of cell age has an effect on the contraction of the lattices. While significance 
of contraction may change dependent upon cell age, the LPD cells had consistently 
greater lattice contraction than the EPD and hTERT cells. The significant differences 
between hTERT and EPD cells varied across time intervals but contraction was not  
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Table 8. Two-way ANOVA table for collagen lattice contraction at 60 
minutes. A P value less than 0.05 shows significance. There was a 
significant difference in cell ages but not in treatment groups. There 
was not a significant interaction between cell age and treatment group. 
A Fisher LSD test showed the lattices with LPD cells were 
significantly different from the lattices with EPD and hTERT cells. 
Source of variation DF SS MS F P 
Cell Age 2 0.0528 0.0264 16.114 <0.001 
Treatment Group 1 0.00107 0.00107 0.653 0.422 
Cell Age x Treatment 2 0.00138 0.00069 0.423 0.657 
Residual 66 0.108 0.00164   
Total 71 0.163 0.00230   
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significantly different at the sixty-minute interval. While treatment caused an interaction 
in the earlier intervals, that influence was not seen at 60 minutes suggesting that cell age 
played the major role in lattice contraction. After one hour of contraction, the LPD 
lattices showed significantly more contraction (21-23% reduction in lattice diameter) than 
the EPD (17-18% reduction) or the hTERT (15-16% reduction) lattices (Figure 9). 
 
Scratch Assay 
 The migration rates of the three cell ages were very similar (Figure 10). Within 
the first 12 hours, the EPD cells migrated into 56% of the wounded area, the LPD cells 
filled in 63% of the wound, and the hTERT cells covered 49% of the wound area. By 18 
hours, the EPD cells had filled in 75% of the area, and 91% by 24 hours. The LPD cells 
were able to migrate into 83% of the area by 18 hours and only filled 99% of the area by 
24 hours. The hTERT cells covered 81% of the wound after 18 hours and 98% by 24 
hours.  
A two-way ANOVA was conducted to evaluate the effects of cell age and time on 
the wound closure area (Table 9). The levels of cell age were early population doubling 
(EPD), late population doubling (LPD), and cells transduced with telomerase (hTERT). 
The levels of time are at 12, 18, and 24 hours after wounding. A significant difference 
was found for the sub effect of time, F(2,45) = 78.733, p < 0.001. The main effect of cell 
age was not significant, F(2,45) = 3.068, p = 0.056. No interaction was found between 
cell age and time, F(4,45) = 1.268, p = 0.297.  
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Figure 10. Effect of cell age on migration. Each graph indicates the decreasing 
size of the wound by plotting the remaining open area. All three cell ages a. EPD 
b. LPD and c. hTERT when combined on a single diagram d. show a similar rate 
of wound closure.    
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Table 9. Two-way ANOVA table for scratch assays. A P value greater than 
0.05 was obtained when comparing cell type indicating no difference. A P 
value of less than 0.05 was obtained when comparing the different time 
points suggesting there is a significant difference. A Fisher LSD test 
indicated a significant difference between every time point.  
Source of Variation DF SS MS F P 
Cell Age 2 0.0575 0.0288 3.068 0.056 
Time (hours) 2 1.476 0.738 78.733 <0.001 
Cell Type x Time 4 0.0475 0.0119 1.268 0.297 
Residual 45 0.422 0.00937   
Total 53 2.003 0.0378   
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A Fisher LSD test showed that there was a significant difference among all time 
points with a significant increase in area covered between each time level for all groups, 
12 vs. 18, (p < 0.001), 12 vs. 24 (p < 0.001), and 18 vs. 24 (p < 0.001).  
43 
DISCUSSION 
 
 Previous experiments have demonstrated that TGF-β1 can induce myofibroblast 
formation on a planar substrate in corneal fibroblasts (Jester et al., 2003), rat dermal 
fibroblasts (Desmouliere et al., 1993), human lung (Hashimoto et al., 2001) and human 
dermal fibroblasts (Vaughan et al., 2000). Our results support these observations. It has 
also been demonstrated that myofibroblasts will differentiate when plated at low 
densities, in the absence of added growth factors (Masur et al., 1996) so the appearance 
of myofibroblasts in the control groups as reported in previous experiments (Desmouiere 
et al. 1993; Vaughan et al., 2000; Robinson and Vaughan, 2007) was expected. For all 
three cell ages, there was a significant difference between the percent of myofibroblasts 
in the control group when compared to the percent of myofibroblasts in the TGF-β1 
group. So a two-day incubation time was sufficient to favor this differentiation. Yet, 
when we compared the EPD and LPD cells in either the TGF-β1 group or the control 
group, there was not a significant difference among the percent of myofibroblasts, 
suggesting the age of the cell does not affect the amount of myofibroblast differentiation 
after two days.  
The hTERT cells, in the TGF-β1 and the control groups, differed significantly 
from both the EPD and LPD cells. This shows that the presence of telomerase in a cell 
does not inhibit the ability of fibroblasts to form myofibroblasts, but may increase 
differentiation. This contradicts work done with lung fibroblasts where induction of 
telomerase reduced differentiation of myofibroblasts (Liu et al., 2006) Nevertheless, 
when comparing the mean number of cells, this two-day time period also allowed for 
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increased proliferation to occur in at least one cell age group. The hTERT cells showed a 
significantly higher mean number of cells than both the EPD and LPD cells. Because the 
mean number of cells within EPD and LPD were similar to each other, if proliferation is 
occurring in these populations, the rate is similar in both groups. Performing an exact cell 
count in future studies could help determine if proliferation, cell death, or some 
combination of the two is occurring within the EPD and LPD cells.   
 Based on the information from the coverslip experiments, similar results were 
expected from the collagen lattice assays. Because myofibroblasts are highly contractile 
(Vaughan et al., 2000), the two-day lattices with TGF-β1 were predicted to contract more 
due to their higher myofibroblast count. Unexpectedly, in the EPD and LPD cells, the 
opposite occurred and more contraction was observed in the control groups. The hTERT 
cells with TGF-β1 had more contraction than the control group; however its overall 
reduction in lattice size was the least of the three cell ages. Increased levels of 
myofibroblasts should correlate to an increase in contraction (Vaughan et al., 2000). 
Surprisingly, our results demonstrated limited myofibroblast differentiation. The largest 
percent of myofibroblasts formed (3.1-3.2%) were in the hTERT cells, but they showed 
the least amount of contraction. The ability of cells to contract a lattice can also depend 
on the number of cells in the lattice: the more cells present, the more likely that 
contraction will occur (Tomasek et al. 1992). Based on the mean number of cells, the 
hTERT lattices had significantly higher amounts of cells than the EPD and LPD, but 
contracted the least. When graphing the cell ages by increasing percentage of contraction, 
along with mean number of cells and percentage of myofibroblasts, the three cell ages 
should follow the same trend. However, as the percent of contraction increased, the mean 
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number of cells and the percentage of myofibroblasts actually decreased (Figure 11). 
Thus, the effects reported may be a result of some other factor.    
 One explanation for the unexpected results is the collagen mixture in which the 
cells were placed. Tension is needed to start the differentiation process (Tomasek et al., 
2002) and coverslips provide immediate tension. However, the collagen lattice does not 
provide tension until the fibroblasts have had a chance to reorganize the lattice (Grinnell, 
1994). At 60 minutes, the EPD and LPD lattices were still contracting, whereas the 
contraction in the hTERT lattices leveled off after about 30 minutes (Figure 9), indicating 
that tension had yet to be fully generated in the EPD and LPD.  Comparing the higher 
percentage of myofibroblasts formed on the coverslips versus the lower percentage of 
myofibroblasts in lattices helps to support the idea that tension in the lattices did not fully 
develop (Figure 12). Therefore, a two-day time period is not enough time for the 
reorganization of the lattice and differentiation of myofibroblasts. With a longer 
incubation time, however, cells may proliferate (Grinnell, 2003) and change the total 
number of cells in the lattice, especially in regard to the hTERT cells thereby creating 
another variable. Future studies may include ways to reduce these proliferation effects; 
Ara-C (cytosine arabinoside) has been previously used (Bell et al., 1979) 
Another explanation comes from studies of the differentiation process. A two-
stage model of myofibroblast formation described by Tomasek et al. (2002) states that 
after tension is created, the fibroblast differentiates first into a protomyofibroblast. A 
protomyofibroblast has some contractile force due to the formation of cytoplasmic actin-
containing stress fibers. From there, the addition of TGF-β1, along with ED-A fibronectin 
and more tension, propels the cell into the myofibroblast phenotype. The lattices in this  
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Figure 11. Comparison of contraction, mean cell number and 
percentage of myofibroblasts for each age of cell. It was expected that 
all three categories would follow a similar trend. However, as the 
contraction rate increased, the mean number of cells and percentage of 
myofibroblasts tended to decrease.  
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Figure 12. Comparison of percentage of myofibroblasts formed on 
coverslips and in collagen lattices. Coverslips, as expected, provided an 
environment for myofibroblast differentiation; however, the collagen 
lattices were unable to do so. 
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study may have more cells in the protomyofibroblast stage.  Because a 
protomyofibroblast can generate some contractile force, this limited force could account 
for the amount of contraction that occurred. TGF-β1 may not promote differentiation 
until after the protomyofibroblasts have formed. Hence, the lack of contraction from the 
TGF-β1 groups in the EPD and LPD cell ages may be due to: 1) an insufficient amount of 
time to allow the formation of protomyofibroblasts, rendering TGF-β1 insignificant at 
this point or, 2) after stimulation by TGF-β1 the protomyofibroblast may lose some 
contractile force while becoming a true myofibroblast. Staining for the presence of 
protomyofibroblasts may help to determine which mechanism contributes to the 
decreased contraction.    
A third option could be the concentration of collagen in the lattices. In prior 
works by Tomasek (1992) and Vaughan (2000) the collagen concentration was 0.65 
mg/mL, and Robinson and Vaughan (2007) used a concentration of 0.60 mg/mL. In this 
study 0.69 mg/mL was the final concentration and may have created an environment that 
was harder to contract.  
None of the above hypotheses address mean cell number or why the large number 
of cells in the hTERT lattices had the least amount of contraction. Within the lattices, the 
distribution of LPD and EPD cells was scattered (Figure 13). The distribution within the 
hTERT cells, however, was clumped. This clumping may be due to the cells sticking 
together as they were mixed in the collagen, or the cells could be proliferating without 
migrating. Either way this clumping of cells may have an effect on the ability of the cells 
to contract the lattice. Future studies should look at ways to compensate for this  
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Figure 13. Distribution of cells within collagen 
lattices. a. hTERT cells appeared clumped (as 
demonstrated within the circle); whereas b. EPD 
cells and c. LPD cells appeared to be scattered as 
single cells. 
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 proliferation by either inhibiting proliferation by CDK inhibitors or doing a dose 
response assay to find a dose of TGF-β1 that will stop proliferation but still allow 
differentiation.  
Many proliferation inhibitors affect the integrity of the cytoskeleton and cannot be 
used due to the need for cytoskeletal integrity within the cells (Tomasek et al., 1992). 
Another option would be to do a final cell count on the hTERT lattices and increase the 
initial EPD and LPD cell concentrations so that after two days the numbers of cells in all 
lattices would be similar. Contractile ability could also be measured by the ability of cells 
to wrinkle a silicone substrate at various stiffness levels (Hinz et al., 2001). This would 
allow single cell measurements instead of whole-population effects. 
The scratch assay did not show any significant differences in migration rates 
between the three ages of cells. However, there was a significant difference between each 
time period and the next. This may indicate a consistent rate of migration until the wound 
is closed. There does not appear to be a time when the cells are moving at a more rapid or 
at a decreased rate to close in the gaps. Since the GTPases Ras, Rac, and Rho all play a 
part in cell movement (Nobes and Hall, 1999) the regulation of these enzymes may not be 
affected by the age of the cell or the expression of telomerase. Analyzing the activity 
levels of these enzymes during similar studies may help to explain the lack of differences 
seen in the scratch assays or whether they are affected by age or telomerase. Future 
studies could also evaluate the migration through collagen substrates that mimic intact 
collagen fibers, as found in younger skin, and fragmented fibers, as demonstrated in aged 
skin (Fisher et al., 2009). 
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The increased proliferation, lack of response in the collagen lattice assay and 
clumping of the hTERT cells may be due to the expression of telomerase over extended 
population doublings. The PD of the cells in this study ranged from 145 to 159. When the 
lattice contractions were compared to previous work done by Robinson and Vaughan 
(2007), the results were not consistent and the PD of the cells in those studies ranged 
from 69 to 81. Overexpression of telomerase in CD8 positive t-cells causes an increase in 
proliferation and sustained overexpression in CD4 and CD8 positive cells promoted 
genomic instability (Aubert and Lansdorp, 2008). The unusual behavior of the hTERT 
CT4 cells may be due to the prolonged expression of telomerase. Future studies could 
investigate the effects of telomerase expression to possibly determine if and when the 
expression of telomerase starts to have an adverse affect on the cells. Knowing more 
about the effects of telomerase over time and how cells may change due to a constant 
expression of telomerase could have an impact on understanding how cells become 
cancerous since telomerase is expressed in > 90% of tumor samples (Aubert and 
Lansdorp, 2008). Transient expression of telomerase may be able to rescue a fibroblast 
from replicative senescence while minimizing the risk of cancer (Steinert et al., 2000). 
With the increased use of telomeres as a biomarker for aging and their correlation to age-
related diseases (von Zglinicki and Martin-Ruiz, 2005), a deeper understanding of 
telomerase may lead to therapies for some of these diseases. 
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CONCLUSIONS 
TGF-β1 induced myofibroblast differentiation when the cells were placed in an 
environment with tension regardless of age or telomerase expression. After a two-day 
period with sufficient tension, the cell age did not affect the percent of myofibroblasts 
formed, but telomerase did. Myofibroblast formation was limited after a two-day period 
without sufficient tension, irrespective of age or telomerase expression. Neither cell age 
nor telomerase expression affected the fibroblasts’ ability to migrate into a wounded area. 
The null hypothesis was that there would be no difference among the three cell ages 
(early passage, late passage, and hTERT) in the number of myofibroblasts, the ability to 
contract or migration time. This hypothesis was rejected and the alternate hypothesis that 
there would be a difference among the cell ages in the number of myofibroblasts, the 
ability to contract or migration time was accepted.  The addition of telomerase increased 
myofibroblast formation, limited the contraction and had no affect on the migration. 
Overall, the results showed that replicative senescence did not have an effect on 
myofibroblast formation or migration, but can affect contraction rate. 
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1a. Raw data for coverslips: EPD control groups 
  fov 
number 
of nuclei 
# of a-sma 
cells % a-sma   fov 
number of 
nuclei 
# of a-sma 
cells % a-sma 
2 day 
EPD 
control 
090330 
1 8 0 0.000 
2 day 
EPD 
control 
090401 
1 8 5 62.500 
2 6 3 50.000 2 8 3 37.500 
3 10 2 20.000 3 9 0 0.000 
4 7 3 42.857 4 9 2 22.222 
5 9 0 0.000 5 10 2 20.000 
6 9 2 22.222 6 10 2 20.000 
7 9 2 22.222 7 5 1 20.000 
8 6 5 83.333 8 9 4 44.444 
9 10 4 40.000 9 13 4 30.769 
10 8 2 25.000 10 6 0 0.000 
11 11 3 27.273 11 8 4 50.000 
12 7 2 28.571 12 10 4 40.000 
total   100 28 36.148 total   105 31 34.744 
avg   8.3333 2.33333   avg   8.75 2.58333   
  fov 
number 
of nuclei 
# of a-sma 
cells % a-sma   fov 
number of 
nuclei 
# of a-sma 
cells % a-sma 
2 day 
EPD 
control 
090506 
1 7 0 0.000 
2 day 
EPD 
control 
090506 
1 11 0 0.000 
2 10 3 30.000 2 8 0 0.000 
3 10 3 30.000 3 11 2 18.182 
4 7 3 42.857 4 10 0 0.000 
5 11 2 18.182 5 6 2 33.333 
6 8 2 25.000 6 5 1 20.000 
7 10 2 20.000 7 9 1 11.111 
8 7 3 42.857 8 9 2 22.222 
9 8 3 37.500 9 12 2 16.667 
10 9 1 11.111 10 14 4 28.571 
11 8 1 12.500 11 11 2 18.182 
12 11 1 9.091 12 6 1 16.667 
total   106 24 27.910 total   112 17 18.494 
avg   8.8333 2   avg   9.33333 1.41667   
  fov 
number of 
nuclei 
# of a-sma 
cells % a-sma   fov number of nuclei 
# of a-sma 
cells % a-sma 
2 day 
EPD 
control 
090530 
1 10 1 10.000 
2 day 
EPD 
control 
090530 
1 11 2 18.182 
2 7 2 28.571 2 13 1 7.692 
3 9 0 0.000 3 11 4 36.364 
4 8 4 50.000 4 10 0 0.000 
5 15 2 13.333 5 12 0 0.000 
6 19 4 21.053 6 10 2 20.000 
7 22 3 13.636 7 12 3 25.000 
8 12 2 16.667 8 13 2 15.385 
9 17 2 11.765 9 8 1 12.500 
10 12 2 16.667 10 14 0 0.000 
11 12 3 25.000 11 12 4 33.333 
12 14 1 7.143 12 6 1 16.667 
total   157 26 21.383 total   132 20 18.512 
avg   13.083 2.16667   avg   11 1.66667   
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1b. Raw date for coverslips: EPD TGF-β groups 
  fov 
number 
of nuclei 
# of a-sma 
cells % a-sma   fov 
number of 
nuclei 
# of a-sma 
cells % a-sma 
2 day 
EPD 
TGF-B 
090330 
1 7 5 71.429 
2 day 
EPD 
TGF-B 
090401 
1 9 4 44.444 
2 9 7 77.778 2 7 5 71.429 
3 7 5 71.429 3 8 6 75.000 
4 6 5 83.333 4 5 4 80.000 
5 6 6 100.000 5 7 4 57.143 
6 7 7 100.000 6 6 5 83.333 
7 9 5 55.556 7 6 2 33.333 
8 8 8 100.000 8 8 6 75.000 
9 8 8 100.000 9 5 4 80.000 
10 8 4 50.000 10 6 5 83.333 
11 11 11 100.000 11 7 2 28.571 
12 8 7 87.500 12 6 4 66.667 
total   94 78 99.702 total   80 51 77.825 
avg   7.8333 6.5   avg   6.66667 4.25   
  fov 
number 
of nuclei 
# of a-sma 
cells % a-sma   fov 
number of 
nuclei 
# of a-sma 
cells % a-sma 
2 day 
EPD 
TGF-B 
090506 
1 19 8 42.105 
2 day 
EPD 
TGF-B 
090506 
1 13 4 30.769 
2 14 7 50.000 2 9 6 66.667 
3 9 7 77.778 3 9 3 33.333 
4 6 3 50.000 4 6 2 33.333 
5 6 4 66.667 5 9 3 33.333 
6 13 5 38.462 6 10 6 60.000 
7 13 6 46.154 7 6 4 66.667 
8 9 6 66.667 8 12 8 66.667 
9 17 9 52.941 9 9 5 55.556 
10 12 5 41.667 10 11 6 54.545 
11 10 5 50.000 11 10 5 50.000 
12 13 7 53.846 12       
total   141 72 63.629 total   104 52 55.087 
avg   11.75 6   avg   8.66667 4.33333   
  fov 
number 
of nuclei 
# of a-sma 
cells % a-sma   fov 
number of 
nuclei 
# of a-sma 
cells % a-sma 
2 day 
EPD 
TGF-B 
090530 
1 12 8 66.667 
2 day 
EPD 
TGF-B 
090530 
1 8 5 62.500 
2 12 9 75.000 2 11 10 90.909 
3 23 15 65.217 3 11 7 63.636 
4 16 9 56.250 4 7 5 71.429 
5 12 4 33.333 5 18 14 77.778 
6 11 7 63.636 6 9 4 44.444 
7 7 5 71.429 7 16 11 68.750 
8 8 2 25.000 8 14 8 57.143 
9 13 7 53.846 9 10 2 20.000 
10 8 2 25.000 10 14 6 42.857 
11 20 11 55.000 11 12 4 33.333 
12 11 8 72.727 12 11 6 54.545 
total   153 87 66.311 total   141 82 68.733 
avg   12.75 7.25   avg   11.75 6.83333   
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1c. Raw data for coverslips: LPD control groups 
  fov 
number 
of nuclei 
# of a-sma 
cells % a-sma   fov 
number of 
nuclei 
# of a-sma 
cells % a-sma 
2 day 
LPD 
control 
090330 
1 7 0 0.000 
2 day 
LPD 
control 
090401 
1 7 7 100.000 
2 16 2 12.500 2 7 4 57.143 
3 11 0 0.000 3 8 1 12.500 
4 9 1 11.111 4 11 3 27.273 
5 15 1 6.667 5 8 3 37.500 
6 12 4 33.333 6 5 3 60.000 
7 6 1 16.667 7 11 2 18.182 
8 12 2 16.667 8 7 0 0.000 
9 6 0 0.000 9 8 1 12.500 
10 13 0 0.000 10 7 1 14.286 
11 15 2 13.333 11 10 0 0.000 
12 8 2 25.000 12 9 0 0.000 
total   130 15 13.528 total   98 25 33.938 
avg   10.833 1.25   avg   8.16667 2.08333   
  fov 
number 
of nuclei 
# of a-sma 
cells % a-sma   fov 
number of 
nuclei 
# of a-sma 
cells % a-sma 
2 day 
LPD 
control 
090506 
1 8 1 12.500 
2 day 
LPD 
control 
090506 
1 5 1 20.000 
2 11 3 27.273 2 5 2 40.000 
3 6 2 33.333 3 6 0 0.000 
4 7 1 14.286 4 8 2 25.000 
5 6 1 16.667 5 8 2 25.000 
6 7 2 28.571 6 9 1 11.111 
7 6 3 50.000 7 8 1 12.500 
8 11 0 0.000 8 9 3 33.333 
9 5 2 40.000 9 6 0 0.000 
10 12 1 8.333 10 8 0 0.000 
11 9 3 33.333 11 12 2 16.667 
12 5 1 20.000 12 12 1 8.333 
total   93 20 28.430 total   96 15 19.194 
avg   7.75 1.66667   avg   8 1.25   
  fov 
number of 
nuclei 
# of a-sma 
cells % a-sma   fov 
number of 
nuclei 
# of a-sma 
cells % a-sma 
2 day 
LPD 
control 
090530 
1 12 1 8.333 
2 day 
LPD 
control 
090530 
1 8 3 37.500 
2 10 2 20.000 2 18 8 44.444 
3 11 1 9.091 3 8 3 37.500 
4 18 4 22.222 4 16 3 18.750 
5 9 3 33.333 5 11 3 27.273 
6 10 2 20.000 6 16 2 12.500 
7 11 3 27.273 7 15 3 20.000 
8 25 7 28.000 8 14 6 42.857 
9 12 4 33.333 9 8 0 0.000 
10 15 4 26.667 10 12 3 25.000 
11 18 5 27.778 11 19 1 5.263 
12 17 7 41.176 12 18 3 16.667 
total   168 43 29.721 total   163 38 28.775 
avg   14 3.58333   avg   13.5833 3.16667   
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1d. Raw data for coverslips: LPD TGF-β groups 
  fov 
number 
of nuclei 
# of a-sma 
cells % a-sma   fov 
number of 
nuclei 
# of a-sma 
cells % a-sma 
2 day 
LPD 
TGF-B 
090330 
1 14 5 35.714 
2 day 
LPD 
TGF-B 
090401 
1 9 4 44.444 
2 10 4 40.000 2 6 4 66.667 
3 14 6 42.857 3 6 5 83.333 
4 9 2 22.222 4 11 8 72.727 
5 9 0 0.000 5 6 2 33.333 
6 5 4 80.000 6 6 5 83.333 
7 10 4 40.000 7 5 3 60.000 
8 10 2 20.000 8 8 7 87.500 
9 11 3 27.273 9 6 2 33.333 
10 14 4 28.571 10 7 4 57.143 
11 10 6 60.000 11 6 3 50.000 
12 14 6 42.857 12 6 5 83.333 
total   130 46 43.949 total   82 52 75.515 
avg   10.833 3.83333   avg   6.83333 4.33333   
  fov 
number 
of nuclei 
# of a-sma 
cells % a-sma   fov 
number of 
nuclei 
# of a-sma 
cells % a-sma 
2 day 
LPD 
TGF-B 
090506 
1 7 6 85.714 
2 day 
LPD 
TGF-B 
090506 
1 7 2 28.571 
2 11 5 45.455 2 7 2 28.571 
3 11 6 54.545 3 9 3 33.333 
4 7 8 114.286 4 7 5 71.429 
5 9 4 44.444 5 11 4 36.364 
6 10 5 50.000 6 6 2 33.333 
7 6 3 50.000 7 6 3 50.000 
8 11 5 45.455 8 6 0 0.000 
9 7 2 28.571 9 8 2 25.000 
10 6 4 66.667 10 12 4 33.333 
11 13 4 30.769 11 11 4 36.364 
12 15 4 26.667 12 12 4 33.333 
total   113 56 64.257 total   102 35 40.963 
avg   9.4167 4.66667   avg   8.5 2.91667   
  fov 
number of 
nuclei 
# of a-sma 
cells % a-sma   fov 
number of 
nuclei 
# of a-sma 
cells % a-sma 
2 day 
LPD 
TGF-B 
090530 
1 9 6 66.667 
2 day 
LPD 
TGF-B 
090530 
1 11 7 63.636 
2 13 7 53.846 2 11 8 72.727 
3 12 9 75.000 3 10 8 80.000 
4 10 7 70.000 4 11 8 72.727 
5 8 7 87.500 5 15 10 66.667 
6 11 7 63.636 6 13 8 61.538 
7 9 5 55.556 7 7 4 57.143 
8 17 12 70.588 8 14 11 78.571 
9 11 8 72.727 9 9 6 66.667 
10 11 9 81.818 10 8 4 50.000 
11 9 6 66.667 11 8 4 50.000 
12 12 6 50.000 12 11 5 45.455 
total   132 89 81.401 total   128 83 76.513 
avg   11 7.41667   avg   10.6667 6.91667   
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1e. Raw data for coverslips: hTERT control groups 
   fov 
number 
of nuclei 
# of a-sma 
cells % a-sma   fov 
number of 
nuclei 
# of a-sma 
cells % a-sma 
2 day 
hTERT 
control 
090330 
1 20 8 40.000 
2 day 
hTERT 
control 
090401 
1 7 6 85.714 
2 30 23 76.667 2 10 9 90.000 
3 13 11 84.615 3 14 10 71.429 
4 15 13 86.667 4 10 9 90.000 
5 24 24 100.000 5 10 10 100.000 
6 31 28 90.323 6 12 12 100.000 
7 21 13 61.905 7 8 7 87.500 
8 21 16 76.190 8 8 8 100.000 
9 13 13 100.000 9 17 17 100.000 
10 22 18 81.818 10 23 10 43.478 
total   210 167 79.818 total   119 98 86.812 
avg   21 16.7   avg   11.9 9.8   
  fov  
number 
of nuclei 
# of a-sma 
cells % a-sma    fov 
number of 
nuclei 
# of a-sma 
cells % a-sma 
2 day 
hTERT 
control 
090506 
1 14 13 92.857 
2 day 
hTERT 
control 
090506 
1 11 11 100.000 
2 9 9 100.000 2 11 9 81.818 
3 12 11 91.667 3 9 8 88.889 
4 17 13 76.471 4 14 10 71.429 
5 14 13 92.857 5 9 8 88.889 
6 10 10 100.000 6 9 9 100.000 
7 23 22 95.652 7 11 11 100.000 
8 8 6 75.000 8 29 22 75.862 
9 23 21 91.304 9 22 14 63.636 
10 10 10 100.000 10 9 6 66.667 
total   140 128 91.581 total   134 108 83.719 
avg   14 12.8   avg   13.4 10.8   
   fov 
number 
of nuclei 
# of a-sma 
cells % a-sma   fov  
number of 
nuclei 
# of a-sma 
cells % a-sma 
2 day 
hTERT 
control 
090530 
1 10 9 90.000 
2 day 
hTERT 
control 
090530 
1 12 8 66.667 
2 22 19 86.364 2 31 20 64.516 
3 25 19 76.000 3 38 24 63.158 
4 13 11 84.615 4 24 12 50.000 
5 17 13 76.471 5 26 15 57.692 
6 30 20 66.667 6 13 10 76.923 
7 17 14 82.353 7 21 12 57.143 
8 11 10 90.909 8 20 12 60.000 
9 27 20 74.074 9 26 15 57.692 
10 16 10 62.500 10 21 14 66.667 
total   188 145 78.995 total   232 142 62.046 
avg   18.8 14.5   avg   23.2 14.2   
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1f. Raw data for coverslips: hTERT TGF-β groups 
  fov  
number 
of nuclei 
# of a-sma 
cells % a-sma    fov 
number of 
nuclei 
# of a-sma 
cells % a-sma 
2 day 
hTERT 
TGF-B 
090330 
1 14 11 78.571 
2 day 
hTERT 
TGF-B 
090401 
1 12 12 100.000 
2 14 14 100.000 2 7 6 85.714 
3 17 17 100.000 3 19 19 100.000 
4 16 16 100.000 4 21 20 95.238 
5 20 18 90.000 5 13 13 100.000 
6 16 16 100.000 6 8 8 100.000 
7 19 18 94.737 7 27 23 85.185 
8 24 24 100.000 8 16 14 87.500 
9 12 12 100.000 9 7 7 100.000 
10 11 11 100.000 10 9 9 100.000 
total   163 157 96.331 total   139 131 95.364 
avg   16.3 15.7   avg   13.9 13.1   
  fov  
number 
of nuclei 
# of a-sma 
cells % a-sma   fov  
number of 
nuclei 
# of a-sma 
cells % a-sma 
2 day 
hTERT 
TGF-B 
090506 
1 14 10 71.429 
2 day 
hTERT 
TGF-B 
090506 
1 12 12 100.000 
2 6 5 83.333 2 13 11 84.615 
3 7 6 85.714 3 8 8 100.000 
4 28 27 96.429 4 11 10 90.909 
5 7 7 100.000 5 12 11 91.667 
6 15 14 93.333 6 21 18 85.714 
7 43 41 95.349 7 18 17 94.444 
8 10 8 80.000 8 20 16 80.000 
9 14 13 92.857 9 14 14 100.000 
10 10 10 100.000 10 10 10 100.000 
total   154 141 89.844 total   139 127 92.735 
avg   15.4 14.1   avg   13.9 12.7   
  fov  
number 
of nuclei 
# of a-sma 
cells % a-sma   fov  
number of 
nuclei 
# of a-sma 
cells % a-sma 
2 day 
hTERT 
TGF-B 
090530 
1 12 9 75.000 
2 day 
hTERT 
TGF-B 
090530 
1 15 14 93.333 
2 15 12 80.000 2 17 16 94.118 
3 16 16 100.000 3 14 13 92.857 
4 18 18 100.000 4 13 13 100.000 
5 13 12 92.308 5 11 11 100.000 
6 16 16 100.000 6 11 11 100.000 
7 10 10 100.000 7 12 12 100.000 
8 15 13 86.667 8 17 15 88.235 
9 29 28 96.552 9 14 14 100.000 
10 12 12 100.000 10 16 15 93.750 
total   156 146 93.053 total   140 134 96.229 
avg   15.6 14.6   avg   14 13.4   
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2a. Raw data for collagen lattice myofibroblast formation: EPD control and TGF-β 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  fov 
number 
of nuclei 
# of    
a-sma 
cells 
% a-
sma     fov 
number 
of 
nuclei 
# of   
a-sma 
cells 
% a-
sma 
2 day 
EPD 
control 
090530 
1 33 3 9.091   
2 day 
EPD 
control 
090530 
1 41 2 4.878 
2 28 0 0.000   2 43 1 2.326 
3 42 1 2.381   3 34 1 2.941 
4 29 0 0.000   4 48 1 2.083 
5 33 0 0.000   5 35 0 0.000 
total   165 4 1.147   total   201 5 1.223 
avg   33 0.8     avg   40.2 1   
                      
  fov 
number 
of nuclei 
# of    
a-sma 
cells 
% a-
sma     fov 
number 
of 
nuclei 
# of   
a-sma 
cells 
% a-
sma 
2 day 
EPD 
TGF-B 
090530 
1 19 1 5.263   
2 day 
EPD 
TGF-B 
090530 
1 26 1 3.846 
2 28 0 0.000   2 39 1 2.564 
3 33 4 12.121   3 44 1 2.273 
4 34 0 0.000   4 34 2 5.882 
5 28 2 7.143   5 36 1 2.778 
total   142 7 2.453   total   179 6 1.734 
avg   28.4 1.4     avg   35.8 1.2   
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2b. Raw data for collagen lattice myofibroblast formation: LPD control and TGF-β 
 
 
 
 
  fov 
number 
of nuclei 
# of    
a-sma 
cells 
% a-
sma     fov 
number 
of 
nuclei 
# of   
a-sma 
cells 
% a-
sma 
2 day 
LPD 
control 
090530 
1 18 2 11.111   
2 day 
LPD 
control 
090530 
1 27 0 0.000 
2 26 0 0.000   2 25 2 8.000 
3 22 0 0.000   3 32 0 0.000 
4 28 2 7.143   4 35 0 0.000 
5 20 0 0.000   5 23 0 0.000 
total   114 4 1.825   total   142 2 0.800 
avg   22.8 0.8     avg   28.4 0.4   
                      
  fov 
number 
of nuclei 
# of    
a-sma 
cells 
% a-
sma     fov 
number 
of 
nuclei 
# of   
a-sma 
cells 
% a-
sma 
2 day 
LPD 
TGF-B 
090530 
1 32 1 3.125   
2 day 
LPD 
TGF-B 
090530 
1 23 0 0.000 
2 23 1 4.348   2 28 1 3.571 
3 29 1 3.448   3 26 1 3.846 
4 39 1 2.564   4 26 0 0.000 
5 26 2 7.692   5 26 1 3.846 
total   149 6 2.118   total   129 3 1.126 
avg   29.8 1.2     avg   25.8 0.6   
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2c. Raw data for collagen lattice myofibroblast formation: hTERT control and TGF-β 
 
 
 
 
  fov 
number 
of nuclei 
# of    
a-sma 
cells 
% a-
sma     fov 
number 
of 
nuclei 
# of   
a-sma 
cells 
% a-
sma 
2 day 
hTERT 
control 
090530 
1 65 7 10.769   
2 day 
hTERT 
control 
090530 
1 65 0 0.000 
2 36 4 11.111   2 46 4 8.696 
3 69 3 4.348   3 80 5 6.250 
4 41 2 4.878   4 55 2 3.636 
5 120 10 8.333   5 31 1 3.226 
total   331 26 3.944   total   277 12 2.181 
avg   66.2 5.2     avg   55.4 2.4   
                      
  fov 
number 
of nuclei 
# of    
a-sma 
cells 
% a-
sma     fov 
number 
of 
nuclei 
# of   
a-sma 
cells 
% a-
sma 
2 day 
hTERT 
TGF-B 
090530 
1 57 3 5.263   
2 day 
hTERT 
TGF-B 
090530 
1 62 2 3.226 
2 51 4 7.843   2 43 0 0.000 
3 58 3 5.172   3 62 1 1.613 
4 37 9 24.324   4 48 1 2.083 
5 82 7 8.537   5 94 5 5.319 
total   285 26 5.114   total   309 9 1.224 
avg   57 5.2     avg   61.8 1.8   
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3a. Raw data for collagen lattice reduction: EPD control and TGF-β groups 
 
 
EX 090530 - EPD Lattice Size (mm) Relative Lattice Diameter 
treatment dish 0 2 10 30 60 0 2 10 30 60 
TGF 4 14.75 14 14 13 11 1 0.949 0.949 0.881 0.746 
TGF 6 15 15 15 14 12.5 1 1.000 1.000 0.933 0.833 
TGF 8 15.5 14.5 14.5 13.5 11.5 1 0.935 0.935 0.871 0.742 
TGF 10 15.5 15 15 14.5 13 1 0.968 0.968 0.935 0.839 
TGF 12 15.5 15.5 15.25 14 12.75 1 1.000 0.984 0.903 0.823 
TGF 16 15 15 14.5 13 12 1 1.000 0.967 0.867 0.800 
                        
Control 3 16.5 15.75 15.5 14 12.5 1 0.955 0.939 0.848 0.758 
Control 5 15.5 15.5 15.5 14.5 13.5 1 1.000 1.000 0.935 0.871 
Control 7 16.5 15.5 15.5 14.5 13 1 0.939 0.939 0.879 0.788 
Control 9 15.25 14.5 14.5 13.5 12 1 0.951 0.951 0.885 0.787 
Control 13 15.5 15 14.5 13.5 12.5 1 0.968 0.935 0.871 0.806 
Control 15 15.5 15 14.5 13.5 12.5 1 0.968 0.935 0.871 0.806 
                        
EX 090615 -EPD Lattice Size (mm) Relative Lattice Diameter 
treatment dish 0 2 10 30 60 0 2 10 30 60 
TGF 2 15 15 15 14.5 13 1 1.000 1.000 0.967 0.867 
TGF 4 15.25 15.25 15 14.5 13 1 1.000 0.984 0.951 0.852 
TGF 6 15.75 15.5 15 14.5 13 1 0.984 0.952 0.921 0.825 
TGF 8 15.5 15 15 15 14 1 0.968 0.968 0.968 0.903 
TGF 10 15 15 15 15 13 1 1.000 1.000 1.000 0.867 
TGF 14 14.25 14 14 13 12.5 1 0.982 0.982 0.912 0.877 
                        
Control 3 15 15 14 13 12 1 1.000 0.933 0.867 0.800 
Control 5 15.5 15 14.25 13.5 14 1 0.968 0.919 0.871 0.903 
Control 7 15.25 14 14 13 12 1 0.918 0.918 0.852 0.787 
Control 11 14.5 13.5 13.5 12.75 12 1 0.931 0.931 0.879 0.828 
Control 13 14 13.5 13 12.25 12 1 0.964 0.929 0.875 0.857 
Control 15 14.5 13.75 13.5 12.5 12 1 0.948 0.931 0.862 0.828 
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3b. Raw data for collagen lattice reduction: LPD control and TGF-β groups 
 
EX 090530 - LPD Lattice Size (mm) Relative Lattice Diameter 
treatment dish 0 2 10 30 60 0 2 10 30 60 
TGF 2 15.5 15 15 14 13 1 0.968 0.968 0.903 0.839 
TGF 6 15 14.5 14 13 12 1 0.967 0.933 0.867 0.800 
TGF 8 14.75 14 14 13 11.5 1 0.949 0.949 0.881 0.780 
TGF 10 16 15.5 15.5 13.75 12.5 1 0.969 0.969 0.859 0.781 
TGF 12 15.75 15 15 13.5 12 1 0.952 0.952 0.857 0.762 
TGF 16 15 14.75 14 12.5 11.25 1 0.983 0.933 0.833 0.750 
                        
Control 1 15.5 15 14.5 13 12 1 0.968 0.935 0.839 0.774 
Control 5 15.5 14.5 14.5 13.5 12.5 1 0.935 0.935 0.871 0.806 
Control 7 16 15 14.75 13 12 1 0.938 0.922 0.813 0.750 
Control 9 15.5 14.5 14 13 11.5 1 0.935 0.903 0.839 0.742 
Control 11 15.75 15 14.5 13.5 12.5 1 0.952 0.921 0.857 0.794 
Control 15 15.25 15 14 13 12 1 0.984 0.918 0.852 0.787 
                        
EX 090615 -LPD Lattice Size (mm) Relative Lattice Diameter 
treatment dish 0 2 10 30 60 0 2 10 30 60 
TGF 3 15.75 15 15 14 14 1 0.952 0.952 0.889 0.889 
TGF 5 15.25 14.5 13.5 13.5 11.5 1 0.951 0.885 0.885 0.754 
TGF 7 15.5 14.5 14 14 13 1 0.935 0.903 0.903 0.839 
TGF 9 15 14 13.5 12 11 1 0.933 0.900 0.800 0.733 
TGF 11 15 14.5 13.5 13 12 1 0.967 0.900 0.867 0.800 
TGF 15 16 14.5 14.5 13 12 1 0.906 0.906 0.813 0.750 
                        
Control 2 15.25 14.5 14 12.5 12 1 0.951 0.918 0.820 0.787 
Control 6 15 14 13 12 12 1 0.933 0.867 0.800 0.800 
Control 8 15 14 13 12 11.5 1 0.933 0.867 0.800 0.767 
Control 10 15 14 13 12 11 1 0.933 0.867 0.800 0.733 
Control 14 14.5 14 13.25 12 11 1 0.966 0.914 0.828 0.759 
Control 16 15 14 13 12.75 12 1 0.933 0.867 0.850 0.800 
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3c. Raw data for collagen lattice reduction: hTERT control and TGF-β groups 
 
EX 090530 - hTERT Lattice Size (mm) Relative Lattice Diameter 
treatment dish 0 2 10 30 60 0 2 10 30 60 
TGF 4 15.5 15 14.5 14 14 1.000 0.968 0.935 0.903 0.903 
TGF 6 15 14 13 12.5 12 1.000 0.933 0.867 0.833 0.800 
TGF 10 16 15 14 13 13 1.000 0.938 0.875 0.813 0.813 
TGF 12 15.5 14.5 13.5 12.5 12.5 1.000 0.935 0.871 0.806 0.806 
TGF 14 15.25 14.5 13.5 13 12.5 1.000 0.951 0.885 0.852 0.820 
TGF 16 15.5 15 14 13.5 13.5 1.000 0.968 0.903 0.871 0.871 
                        
Control 3 15 15 14 13 13 1.000 1.000 0.933 0.867 0.867 
Control 7 15.75 15.5 15.5 14.5 14.5 1.000 0.984 0.984 0.921 0.921 
Control 9 15 14.75 14 12.75 12 1.000 0.983 0.933 0.850 0.800 
Control 11 14.5 14.5 14.5 13 13 1.000 1.000 1.000 0.897 0.897 
Control 13 14.5 14.5 13.5 13.5 12.5 1.000 1.000 0.931 0.931 0.862 
Control 15 15.5 15.25 14.5 13.5 12.5 1.000 0.984 0.935 0.871 0.806 
            
EX 090615 -hTERT  Lattice Size (mm) Relative Lattice Diameter 
treatment dish 0 2 10 30 60 0 2 10 30 60 
TGF 2 14.75 13.5 12.5 12 12 1.000 0.915 0.847 0.814 0.814 
TGF 6 14.5 14 13 13 12 1.000 0.966 0.897 0.897 0.828 
TGF 8 15.25 15 14 14 14 1.000 0.984 0.918 0.918 0.918 
TGF 10 15 14.5 13.5 13 13 1.000 0.967 0.900 0.867 0.867 
TGF 12 15.5 14.5 13.5 13.25 13 1.000 0.935 0.871 0.855 0.839 
TGF 16 15 14 14 13 13 1.000 0.933 0.933 0.867 0.867 
                        
Control 3 15 14.75 14 13 13 1.000 0.983 0.933 0.867 0.867 
Control 5 15 14.5 13.75 13.5 13 1.000 0.967 0.917 0.900 0.867 
Control 7 15 15 13.75 13.75 12.5 1.000 1.000 0.917 0.917 0.833 
Control 9 15 14.5 13.5 13 12 1.000 0.967 0.900 0.867 0.800 
Control 11 15 15 14 13.5 12.5 1.000 1.000 0.933 0.900 0.833 
Control 15 14.75 14.5 13.5 13 12.5 1.000 0.983 0.915 0.881 0.847 
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4. Raw Data for Scratch Assays 
  
 
 
 
 
 
 
 
EX 090530  Area (mm
2
) Relative Area 
cell type area 0 12 18 24 0 12 18 24 
EPD 1A 0.25 0.13 0.033 0 1 0.52 0.132 0 
EPD 2A 0.201 0.035 0 0 1 0.174129 0 0 
EPD 3B 0.191 0.085 0.078 0.028 1 0.445026 0.408377 0.146597 
LPD 1A 0.271 0.129 0.042 0.022 1 0.476015 0.154982 0.081181 
LPD 2B 0.272 0.09 0.049 0 1 0.330882 0.180147 0 
LPD 3A 0.149 0.04 0.03 0 1 0.268456 0.201342 0 
hTERT 1A 0.375 0.181 0.046 0 1 0.482667 0.122667 0 
hTERT 2B 0.349 0.165 0.067 0 1 0.472779 0.191977 0 
hTERT 3A 0.378 0.192 0.092 0.032 1 0.507937 0.243386 0.084656 
          
EX 090529 Area (mm
2
) Relative Area 
cell type area 0 12 18 24 0 12 18 24 
EPD 1B 0.237 0.127 0.112 0.07 1 0.535865 0.472574 0.295359 
EPD 2B 0.202 0.089 0.037 0 1 0.440594 0.183168 0 
EPD 3B 0.222 0.12 0.066 0.02 1 0.540541 0.297297 0.09009 
LPD 1A 0.223 0.093 0.031 0 1 0.41704 0.139013 0 
LPD 2A 0.268 0.114 0.064 0 1 0.425373 0.238806 0 
LPD 3B 0.31 0.097 0.025 0 1 0.312903 0.080645 0 
hTERT 1A 0.248 0.14 0.03 0.012 1 0.564516 0.120968 0.048387 
hTERT 2B 0.223 0.113 0.071 0 1 0.506726 0.318386 0 
hTERT 3B 0.254 0.143 0.034 0 1 0.562992 0.133858 0 
